Nolato ABFRA:NBF 82 Quick Ratio is 1.21 as of Mar. 2026, which is 2% below its 10-year median of 1.24. GuruFocus rates FRA:NBF with a GF Score™ of 82/100 and a GF Value™ of €4.74 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Nolato AB ranks worse than 68.27% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Nolato AB's quick ratio for the quarter that ended in Mar. 2026 was 1.21.
Nolato AB has a quick ratio of 1.21. It generally indicates good short-term financial strength.
The historical rank and industry rank for Nolato AB's Quick Ratio or its related term are showing as below:
FRA:NBF'
s Quick Ratio Range Over the Past 10 Years
Min: 0.89 Med: 1.24 Max: 1.58
Current: 1.21
During the past 13 years, Nolato AB's highest Quick Ratio was 1.58. The lowest was 0.89. And the median was 1.24.
FRA:NBF's Quick Ratio is ranked worse than 68.27% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs FRA:NBF: 1.21
Nolato AB (FRA:NBF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Nolato AB Quick Ratio Related Terms
Nolato AB Quick Ratio Historical Data
* Premium members only.
The historical data trend for Nolato AB's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nolato AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Nolato AB's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Nolato AB's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (FRA:NBF) has a Quick Ratio of 1.21 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Nolato AB and its competitors. This is near median its historical median of 1.24. Over the past decade, Nolato AB's Quick Ratio has ranged from 0.89 to 1.58. According to the industry distribution chart, Nolato AB ranks #583 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 68.3%.
Is Nolato AB's Quick Ratio too high?
Nolato AB's current Quick Ratio of 1.21 is near median its 10-year median of 1.24. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 1.58. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Nolato AB's value of 1.21 is 35.1% below this industry median. Based on the distribution chart, Nolato AB ranks #583 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nolato AB has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #583 out of 854 companies for Quick Ratio. This places Nolato AB in the lower half of its industry. The industry median Quick Ratio is 1.87. Nolato AB's value of 1.21 is 35.1% below this benchmark. Historically, Nolato AB's own Quick Ratio has ranged from 0.89 to 1.58 over the past decade. While the company's 10-year median is 1.24 vs. the industry median of 1.87, Nolato AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nolato AB's current Quick Ratio of 1.21 is 35.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current Quick Ratio is 1.21, which is near median its own 10-year median of 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (FRA:NBF) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.74, compared to a current price of €4.28 — trading 9.8% below its estimated fair value. The current Quick Ratio is 1.21, which is near median its 10-year median of 1.24 and 35.1% below the Medical Devices & Instruments industry median of 1.87. Nolato AB's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Nolato AB (FRA:NBF), the current Quick Ratio is 1.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (FRA:NBF) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of €4.28 is trading 9.8% below its estimated GF Value™ of €4.74.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for FRA:NBF:
Quick Ratio: 1.21 (near median its 10-year median of 1.24)
GF Value™: €4.74 vs. price of €4.28 (9.8% below fair value)
Industry Position: 35.1% below the Medical Devices & Instruments median (#583 of 854)
No single metric tells the full story. See the FRA:NBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
82GF Score
Get the complete analysis for FRA:NBF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NBF has been successfully added to your 
